- Technology delivers accurate, real-time glucose readings, eliminating the need for routine fingersticks4 for people living with diabetes
- A quick scan of the FreeStyle Libre sensor worn on the back of the upper arm gives users and their doctors a detailed picture of glucose results and actionable insights
- Multiple, new real-world studies14, 18-20 demonstrate that the use of the FreeStyle Libre system can lead to significant clinical benefits among people living with Type 1 and Type 2 diabetes.
MANILA, Philippines — Abbott, a global healthcare leader, announced today that the FreeStyle Libre system, the world’s leading continuous glucose monitoring (CGM) technology, is now available for adults and children (ages four and up) living with diabetes in the Philippines, offering them more choice, and ultimately improving glucose control.
Simple and discreet for those living with diabetes, the FreeStyle Libre system monitors glucose levels continuously, every minute through a small, coin-sized sensor worn on the back of the upper arm for up to 14 days – making it the longest-lasting CGM available globally.
Since its introduction in 2014, the FreeStyle Libre portfolio has revolutionized the way diabetes is managed globally by over 2 million users across 50 countries. Beyond the proven benefits for people living with Type 1 diabetes, real-world data show the use of FreeStyle Libre significantly reduces HbA1c levels in people with Type 2 diabetes, whether using insulin or not.
How Urban Filipinos Manage Diabetes
A recent Abbott-commissioned survey, titled ‘Diabetes Management Among Urban Filipinos’, among doctors, people with diabetes and caregivers in urban Philippines has found that 8 out of 10 people with diabetes surveyed believe that they manage diabetes ‘well’, but 9 out of 10 respondents have high post-meal glucose levels greater than 140 mg/dL (the American Diabetes Association advises a normal fasting glucose level less than 100 mg/dL and a post-meal level less than 140 mg/dL). The survey also highlights that 62% of the survey’s respondents have HbA1C (glycosylated hemoglobin) of 7 or more, indicating that diabetes is not being managed well over the longer term.
To track their glucose levels, most Filipinos must endure multiple, painful fingersticks each day to ensure they are in a normal glucose range. The Abbott survey also reveals that finger-sticking during blood glucose monitoring is generally rated as a hindrance to effective diabetes management, according to doctors. Mothers of children with diabetes felt that their kids would be able to manage glucose levels better if they did not have to bear finger-sticks.
Mr. Jam Corona from Manila, a FreeStyle Libre user, says “My old glucometers didn’t have a feature to show if my blood sugar is dropping or not, so I’ve suffered hypoglycemia a number of times in the past. This also greatly affected my wife who, unfortunately, has had to bear the heavy emotional burden of coping with my hypoglycemic episodes.
FreeStyle Libre Provides Powerful Health Outcomes
The FreeStyle Libre sensor measures glucose every minute in interstitial fluid through a small (5.5mm long) filament that is inserted just under the skin and held in place with a small adhesive pad. A quick scan of the sensor with a reader provides a real-time glucose reading and a detailed picture of a person’s glucose levels, without the need for painful, routine fingersticks or daily calibration, enabling meaningful lifestyle and therapeutic interventions with actionable insights.
“Filipinos now have a choice of managing diabetes better by making adjustments to diet, medication or lifestyle, as FreeStyle Libre provides actionable information including current glucose levels, 8-hour glucose history, a trend arrow indicating how the glucose is moving and also the time-in-range.”
Clinical trials and real-world data show that users of the FreeStyle Libre system have improved glucose control6, decreased time in hyperglycemia10 and hypoglycemia11 as well as reduced hospitalizations12, HbA1C13 levels, and improved quality of life. Recent findings from the RELIEF study in France14 have shown for the first time, in the largest retrospective analysis of its kind of nearly 75,000 people living with diabetes, the use of the FreeStyle Libre system dramatically decreases diabetic ketoacidosis-related hospitalizations in people living with Type 1 and Type 2 diabetes.
These results are similar to outcomes typically seen when adding insulin therapy to treatment regimens17, indicating people may be able to manage their glucose levels with CGM technology instead of adding insulin.
Dr. Michael Villa of the Philippine Society of Endocrinology & Metabolism said, “FreeStyle Libre’s technology offers a convenient and relatively painless option to get more frequent glucose readings. Compared to a conventional fingerstick method that gives a single glucose reading at just one specific point in time, this technology provides physicians with a comprehensive Ambulatory Glucose Profile and Time-in-Range to help make informed treatment decisions. Recently published data from Japan concludes that flash glucose monitoring technology helps achieve better glycemic control than conventional self-monitoring of blood glucose in people with non-insulin treated type 2 diabetes.”
FreeStyle Libre is available in the Philippines across multiple Mercury Drugstore outlets and can also be purchased at Abbott’s official online store on www.lazada.com.ph/abbott-official-online-store-by-great-deals/.
About the ‘Diabetes Management Among Urban Filipinos’ survey
The survey was commissioned by Abbott and conducted over February-March 2020 by Branding Science, an independent market research consultancy based in London, San Francisco, Singapore, and Manila. The study was conducted across Metro Manila and segmented respondents based on different factors, such as gender, age, type of diabetes, and location. The multi-stakeholder survey was conducted across three respondent categories: people with diabetes, their caregivers, and doctors.
Total sample size covered was 200, comprising 140 people with diabetes, 10 caregivers, and 50 doctors (11 Diabetologists, 35 Endocrinologists, and 4 Paediatric Endocrinologists). All people with diabetes recruited for the survey had been living with diabetes for at least a year.
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, Nutritionals, and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.
